These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 17402325

  • 1. Human papillomavirus vaccine: the beginning of the end for cervical cancer.
    Bornstein J.
    Isr Med Assoc J; 2007 Mar; 9(3):156-8. PubMed ID: 17402325
    [Abstract] [Full Text] [Related]

  • 2. [Vaccination against cervical cancer and diseases caused by Human Papillomavirus].
    Bornstein J, Tuma R, Zarfati D, Ophir E.
    Harefuah; 2007 Oct; 146(10):764-9, 814. PubMed ID: 17990391
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
    Arbyn M, Dillner J.
    J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
    Paavonen J.
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
    [Abstract] [Full Text] [Related]

  • 10. Vaccines against human papillomavirus and cervical cancer: promises and challenges.
    Mahdavi A, Monk BJ.
    Oncologist; 2005 Aug; 10(7):528-38. PubMed ID: 16079320
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER, Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 2007 Mar 23; 56(RR-2):1-24. PubMed ID: 17380109
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Human papillomavirus vaccines].
    Brun JL.
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb 23; 37 Suppl 1():S155-66. PubMed ID: 18187268
    [Abstract] [Full Text] [Related]

  • 15. Human papillomavirus quadrivalent vaccine: a look behind the numbers.
    Flaherty DK, Alkhateeb FM.
    Ann Pharmacother; 2009 Apr 23; 43(4):740-4. PubMed ID: 19276314
    [Abstract] [Full Text] [Related]

  • 16. Human papillomavirus, cervical cancer, and the vaccines.
    Tovar JM, Bazaldua OV, Vargas L, Reile E.
    Postgrad Med; 2008 Jul 23; 120(2):79-84. PubMed ID: 18654072
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D.
    Gynecol Oncol; 2008 Sep 23; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.